These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24812540)

  • 1. Effects of pregabalin in patients with hypnotic-dependent insomnia.
    Cho YW; Song ML
    J Clin Sleep Med; 2014 May; 10(5):545-50. PubMed ID: 24812540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
    Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
    Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample.
    Lichstein KL; Nau SD; Wilson NM; Aguillard RN; Lester KW; Bush AJ; McCrae CS
    Behav Res Ther; 2013 Dec; 51(12):787-96. PubMed ID: 24121096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2020 Jun; 15(2):147-154. PubMed ID: 32386690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
    Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
    Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sleep disorders and hypnotic agents: medical, social and economical impact].
    Touitou Y
    Ann Pharm Fr; 2007 Jul; 65(4):230-8. PubMed ID: 17652991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomnia.
    Bazil CW; Dave J; Cole J; Stalvey J; Drake E
    Epilepsy Behav; 2012 Apr; 23(4):422-5. PubMed ID: 22424859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sedative-hypnotics on sleep quality among patients with insomnia: evidence from an observational, pre-post study in India.
    Satheesh G; Puthean S; Sharma A; Mishra SR; Jose J; Kakkan S; Unnikrishnan MK
    Health Qual Life Outcomes; 2020 Jul; 18(1):212. PubMed ID: 32631438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound insomnia and hypnotic self administration.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of hypnotics during cognitive behavioural therapy for insomnia.
    Zavesicka L; Brunovsky M; Matousek M; Sos P
    BMC Psychiatry; 2008 Sep; 8():80. PubMed ID: 18801160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep restriction therapy and hypnotic withdrawal versus sleep hygiene education in hypnotic using patients with insomnia.
    Taylor DJ; Schmidt-Nowara W; Jessop CA; Ahearn J
    J Clin Sleep Med; 2010 Apr; 6(2):169-75. PubMed ID: 20411695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
    Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T
    Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.
    Hajak G; Lemme K; Zisapel N
    Int Clin Psychopharmacol; 2015 Jan; 30(1):36-42. PubMed ID: 25054634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insomnia due to hypnotic abuse].
    Poluektov MG; Pchelina PV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):24-29. PubMed ID: 28300810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics.
    Pat-Horenczyk R; Hacohen D; Herer P; Lavie P
    Psychopharmacology (Berl); 1998 Dec; 140(4):450-7. PubMed ID: 9888621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.